VANGUARD GROUP INC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$28,017,000
-7.4%
8,240,391
+2.4%
0.00%0.0%
Q2 2018$30,253,000
-4.8%
8,045,954
+3.6%
0.00%0.0%
Q1 2018$31,769,000
-13.5%
7,767,639
-1.6%
0.00%
-50.0%
Q4 2017$36,706,000
-31.7%
7,893,859
+4.3%
0.00%
-33.3%
Q3 2017$53,712,000
+3.2%
7,564,970
+5.1%
0.00%0.0%
Q2 2017$52,043,000
+23.4%
7,198,269
+5.1%
0.00%
+50.0%
Q1 2017$42,188,000
+10.0%
6,848,748
+4.6%
0.00%0.0%
Q4 2016$38,358,000
+12.9%
6,545,762
+2.3%
0.00%0.0%
Q3 2016$33,979,000
-17.2%
6,398,992
+3.2%
0.00%
-33.3%
Q2 2016$41,055,000
+41.7%
6,201,702
-0.0%
0.00%
+50.0%
Q1 2016$28,963,000
-4.5%
6,201,827
+3.3%
0.00%0.0%
Q4 2015$30,312,000
-39.5%
6,002,097
-57.8%
0.00%0.0%
Q3 2015$50,088,000
-26.9%
14,229,376
+107.2%
0.00%
-60.0%
Q2 2015$68,552,000
-17.6%
6,868,851
+5.2%
0.01%
-16.7%
Q1 2015$83,155,000
+3.3%
6,532,220
+14.8%
0.01%0.0%
Q4 2014$80,517,000
+4.7%
5,690,238
+1.8%
0.01%0.0%
Q3 2014$76,873,000
+20.1%
5,590,739
+34.4%
0.01%
+20.0%
Q2 2014$63,985,000
-8.9%
4,160,274
+1.0%
0.01%
-16.7%
Q1 2014$70,208,000
+120.2%
4,120,180
+67.3%
0.01%
+100.0%
Q4 2013$31,885,000
+37.6%
2,462,096
+7.3%
0.00%
+50.0%
Q3 2013$23,176,000
+37.2%
2,294,728
+1.5%
0.00%0.0%
Q2 2013$16,895,0002,261,7730.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders